You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCSK1

Showing 1 - 25 of 314
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Genetic Obesity, POMC Deficiency Obesity, PCSK1 Deficiency Obesity Trial in Paris, Cambridge (LB54640)

Not yet recruiting
  • Genetic Obesity
  • +3 more
  • Paris, France
  • +1 more
Sep 20, 2023

Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway Trial (Setmelanotide, Placebo)

Not yet recruiting
  • Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway
  • (no location specified)
Oct 13, 2021

Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function

Completed
  • POMC Deficiency Obesity
  • +2 more
    • Balçova, Turkey
    • +2 more
    Jun 28, 2021

    NSCLC (NSCLC) Trial (Alirocumab and Cemiplimab)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Alirocumab and Cemiplimab
    • (no location specified)
    Jan 31, 2023

    Adverse Effect of Cardiovascular Medications (Diagnosis) Trial in Zibo (Evolocumab combined with statins, Statin)

    Recruiting
    • Adverse Effect of Cardiovascular Medications (Diagnosis)
    • Evolocumab combined with statins
    • Statin
    • Zibo, Shandong, China
      Zibo Central Hospital
    Mar 24, 2023

    Bardet-Biedl Syndrome, POMC Deficiency Obesity, PCSK1 Deficiency Obesity Trial in Worldwide (Setmelanotide)

    Active, not recruiting
    • Bardet-Biedl Syndrome
    • +3 more
    • Aurora, Colorado
    • +5 more
    Jul 21, 2022

    Sars-CoV-2 Infection Trial in Bydgoszcz (Evolocumab, Saline solution)

    Completed
    • Sars-CoV-2 Infection
    • Bydgoszcz, Poland
      Antoni Jurasz University Hospital No. 1
    Dec 14, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Cholesterol metabolism disruption
    • Quebec city, Quebec, Canada
      CHU de Québec-Université Laval
    Oct 17, 2022

    Sepsis Trial in Atlanta (Alirocumab, Placebo)

    Not yet recruiting
    • Sepsis
    • Atlanta, Georgia
    • +1 more
    Jul 19, 2022

    Pro-opiomelanocortin (POMC) Deficiency Obesity Trial in Worldwide (Setmelanotide, Placebo)

    Completed
    • Pro-opiomelanocortin (POMC) Deficiency Obesity
    • Scottsdale, Arizona
    • +6 more
    Jan 26, 2021

    Severe Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

    Completed
    Has Results
    • Severe Familial Hypercholesterolemia
    • Evolocumab
    • Los Angeles, California
    • +43 more
    Nov 3, 2022

    Hypercholesterolemia Trial in France, United States (Alirocumab, Placebo)

    Completed
    Has Results
    • Hypercholesterolemia
    • Salt Lake City, Utah
    • +3 more
    Jun 4, 2020

    Hyperlipidemia Trial in Worldwide (biological, drug, other)

    Completed
    Has Results
    • Hyperlipidemia
    • Evolocumab
    • +3 more
    • Birmingham, Alabama
    • +82 more
    Nov 4, 2022

    Hypercholesterolemia Trial in Worldwide (biological, drug, other)

    Completed
    Has Results
    • Hypercholesterolemia
    • Evolocumab
    • +4 more
    • Birmingham, Alabama
    • +95 more
    Jul 15, 2022

    Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,

    Not yet recruiting
    • Acute Coronary Syndrome
    • Non ST Segment Elevation Acute Coronary Syndrome
    • (no location specified)
    Oct 20, 2023

    Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

    Completed
    Has Results
    • Hyperlipidemia
    • Evolocumab
    • +6 more
    • Birmingham, Alabama
    • +243 more
    Nov 4, 2022

    ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)

    Recruiting
    • ST Elevation Myocardial Infarction
    • Bucheon, Korea, Republic of
      Sejong General Hospital
    Oct 10, 2023

    PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

    Not yet recruiting
    • Acute Ischemic Stroke
    • (no location specified)
    Nov 14, 2023

    Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic

    Recruiting
    • Atherosclerosis
    • Aortic Valve Disease
    • Thrombotic assessment
    • Measurement of Lp(a)
    • Stevenage, United Kingdom
      East and North Herts NHS Trust
    Nov 6, 2023

    Genetic Research of Monogenic Obesity inPediatric Cohort With

    Not yet recruiting
    • Monogenic Obesity
    • Non Syndromic Obesity
    • monogenic obesity
    • Bordeaux, France
      Centre Hospitalier Universitaire de Bordeaux
    Oct 27, 2023

    Hypercholesterolaemia Trial in Peking (AK102, Placebo)

    Completed
    • Hypercholesterolaemia
    • Peking, China
      Peking Union Medical College Hospital
    Nov 17, 2019

    ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

    Not yet recruiting
    • ST Elevation Myocardial Infarction (STEMI)
    • Rosuvastatin 20 mg
    • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
    • (no location specified)
    Feb 1, 2023

    Qualitative Features of Atherosclerotic Plaques

    Active, not recruiting
    • Atherosclerotic Cardiovascular Disease
    • Riga, Latvia
      Pauls Stradins Clinical University Hospital
    Dec 5, 2022

    Hyperlipemia Trial in Beijing (RBD7022, Placebo)

    Recruiting
    • Hyperlipemia
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 12, 2023

    In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)

    Recruiting
    • In-stent Restenosis
    • Major Adverse Cardiovascular Events
    • Beijing, Beijing, China
      Beijing Anzhen Hospital
    Jan 16, 2023